arrow_back Trending Legislation
Share share

Supporting Glioblastoma Awareness Day

The U.S. House of Representatives supports designating July 19, 2023, as Glioblastoma Awareness Day. This aims to increase public understanding of this aggressive disease, honor patients and their families, and encourage further research into new treatments. Citizens may benefit from greater public awareness and potentially improved access to information about support and research.
Key points
The establishment of Glioblastoma Awareness Day aims to increase public knowledge about this disease, which is the most common and aggressive brain tumor.
The initiative seeks to honor individuals affected by glioblastoma and their caregivers, while also emphasizing the need for continued investment in research for new, more effective treatments.
It supports the development of biomarker testing, crucial for diagnosis and treatment, and encourages collaboration among organizations to accelerate progress in combating the disease.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Supporting the designation of July 19, 2023, as "Glioblastoma Awareness Day".
Print number: HRES 425
Sponsor: Rep. Mast, Brian J. [R-FL-21]
Process start date: 2023-05-18
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Supporting Glioblastoma Awareness Day

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HRES 425.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-05-18.

What are the main provisions?

Key points include:

  • The establishment of Glioblastoma Awareness Day aims to increase public knowledge about this disease, which is the most common and aggressive brain tumor.
  • The initiative seeks to honor individuals affected by glioblastoma and their caregivers, while also emphasizing the need for continued investment in research for new, more effective treatments.
  • It supports the development of biomarker testing, crucial for diagnosis and treatment, and encourages collaboration among organizations to accelerate progress in combating the disease.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Mast, Brian J. [R-FL-21].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

Analysis and Potential Impact of HRES 425

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health